30195-30-3
30195-30-3
Chemical Structure
Ro5-3335
- CAS. Nr.: 30195-30-3
- Formula:C13H10ClN3O
- Molecular Weight:259.69
IUPAC Name: 7-chloro-5-(1H-pyrrol-2-yl)-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one
InChIKey: XWNMORIHKRROGW-UHFFFAOYSA-N
SMILES: O=C1NC2=CC=C(Cl)C=C2C(C3=CC=CN3)=NC1
Biological Activity: Ro5-3335, a benzodiazepine, acts as an inhibitor of core binding factor (CBF) leukemia. Ro5-3335 is a RUNX1-CBFβ interaction inhibitor that represses RUNX1/CBFB-dependent transactivation[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ro5-3335 | 99.35% | Ro5-3335, a benzodiazepine, acts as an inhibitor of core binding factor (CBF) leukemia. Ro5-3335 is a RUNX1-CBFβ interaction inhibitor that represses RUNX1/CBFB-dependent transactivation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ro5-3335 (Standard) | ≥98% | Ro5-3335 (Standard) is the analytical standard of Ro5-3335 (HY-108470). This product is intended for research and analytical applications. Ro5-3335, a benzodiazepine, acts as an inhibitor of core binding factor (CBF) leukemia. Ro5-3335 is a RUNX1-CBFβ interaction inhibitor that represses RUNX1/CBFB-dependent transactivation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
